Shunichiro Shinagawa

Shunichiro Shinagawa M.D., Ph.D.
Professor, Jikei University School of Medicine
Dr. Shunichiro Shinagawa is a Professor in the Department of Psychiatry at Jikei University School of Medicine in Tokyo, Japan. His clinical and research work focuses on geriatric psychiatry, behavioral neurology, and neuropsychiatry, with particular interests in neurodegenerative disorders, late-onset psychosis, and the neuropsychiatric symptoms of dementia. His recent work has emphasized the clinical characterization and neurobiological underpinnings of frontotemporal dementia and other neuropsychiatric syndromes associated with dementia.
Dr. Shinagawa earned his M.D. from Jikei University School of Medicine in 1999 and subsequently completed his residency and fellowship training in psychiatry at Jikei University Hospital. He obtained his Ph.D. from the same university in 2006, during which he also served as a research fellow at the Graduate School of Medicine, Ehime University. From 2012 to 2014, he joined the Memory and Aging Center at the University of California, San Francisco (UCSF), as a visiting research fellow, where he deepened his expertise in neurodegenerative diseases and cognitive neuroscience. Upon returning to Japan, he was appointed Associate Professor (2019–2024) and, since 2024, has served as Professor in the Department of Psychiatry at Jikei University School of Medicine.
Dr. Shinagawa is actively involved in both international and national academic societies. He serves on the Board of Directors of the International Psychogeriatric Association, the Japanese Psychogeriatric Society, and the Japanese Society for Dementia Care. He is also a councilor of the Japanese Society of Psychiatry and Neurology, the Japan Society for Dementia Research, the Neuropsychology Association of Japan, and the Japan Society for Higher Brain Function.
Through his ongoing work, Dr. Shinagawa aims to advance understanding of the neural and clinical mechanisms underlying neuropsychiatric symptoms in dementia and to contribute to the development of person-centered, evidence-based care for older adults with cognitive and psychiatric disorders.


